Migabon, Aliah Mae F.

HRN: 14-05-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFUROXIME 750MG (VIAL)
10/18/2022
10/25/2022
IVT
360 Mg
8 Hrs
PCAP C
Waiting Final Action 
10/19/2022
CEFTRIAXONE 1G (VIAL)
10/19/2022
10/26/2022
IV
1g
Q24h
Pcap C
Waiting Final Action 
10/19/2022
AMPICILLIN 1GM (VIAL)
10/19/2022
10/26/2022
IV
550mg
Q12
Pcap C
Waiting Final Action 
10/21/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/21/2022
10/28/2022
IVT
164 Mg
24 Hrs
PCAP C
Waiting Final Action 
10/22/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
10/22/2022
10/29/2022
PO
3ml
OD
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: